News & Media
Dr. Di Zhao was interviewed by UroToday to discuss our published research “Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies.”
UroToday highlighted our recent publication in Science Translational Medicine.
Zhao Lab research and publications were featured in MD Anderson news releases:
MD Anderson Research Highlights for May 10, 2023
MD Anderson Research Highlights for July 13, 2022
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.